BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 8945479)

  • 21. Activation and serine phosphorylation of the p56lck protein tyrosine kinase in response to antigen receptor cross-linking in B lymphocytes.
    Gold MR; Chiu R; Ingham RJ; Saxton TM; van Oostveen I; Watts JD; Affolter M; Aebersold R
    J Immunol; 1994 Sep; 153(6):2369-80. PubMed ID: 8077654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for the inhibition of tyrosine kinase activity of ZAP-70.
    Deindl S; Kadlecek TA; Brdicka T; Cao X; Weiss A; Kuriyan J
    Cell; 2007 May; 129(4):735-46. PubMed ID: 17512407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Workshop cluster 1, a gammadelta T cell specific receptor is phosphorylated and down regulated by activation induced Src family kinase activity.
    Pillai MR; Lefevre EA; Carr BV; Charleston B; O'Grady P
    Mol Immunol; 2007 Mar; 44(7):1691-703. PubMed ID: 16997376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure function analysis of SH2D2A isoforms expressed in T cells reveals a crucial role for the proline rich region encoded by SH2D2A exon 7.
    Granum S; Sundvold-Gjerstad V; Dai KZ; Kolltveit KM; Hildebrand K; Huitfeldt HS; Lea T; Spurkland A
    BMC Immunol; 2006 Jul; 7():15. PubMed ID: 16839418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redox regulation of a src family protein tyrosine kinase p56lck in T cells.
    Nakamura K; Hori T; Sato N; Sugie K; Kawakami T; Yodoi J
    Oncogene; 1993 Nov; 8(11):3133-9. PubMed ID: 8414515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
    Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
    Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
    Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
    Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.
    Cowan-Jacob SW; Fendrich G; Manley PW; Jahnke W; Fabbro D; Liebetanz J; Meyer T
    Structure; 2005 Jun; 13(6):861-71. PubMed ID: 15939018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posttranslational regulation of Lck and a p36-38 protein by activators of protein kinase C: differential effects of the tumor promoter, PMA, and the non-tumor-promoter, bryostatin.
    Galron D; Ansotegui IJ; Isakov N
    Cell Immunol; 1997 Jun; 178(2):141-51. PubMed ID: 9225005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution.
    Tong L; Warren TC; King J; Betageri R; Rose J; Jakes S
    J Mol Biol; 1996 Mar; 256(3):601-10. PubMed ID: 8604142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The activation loop in Lck regulates oncogenic potential by inhibiting basal kinase activity and restricting substrate specificity.
    Laham LE; Mukhopadhyay N; Roberts TM
    Oncogene; 2000 Aug; 19(35):3961-70. PubMed ID: 10962552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The crystal structures of the SH2 domain of p56lck complexed with two phosphonopeptides suggest a gated peptide binding site.
    Mikol V; Baumann G; Keller TH; Manning U; Zurini MG
    J Mol Biol; 1995 Feb; 246(2):344-55. PubMed ID: 7532720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Src-homology domain 2 is responsible for transcriptional suppression induced by expression of Lck.
    Ohta M; Nagai H; Nyunoya H; Shimotohno K
    Oncogene; 1996 Mar; 12(5):989-97. PubMed ID: 8649816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis for activation of ZAP-70 by phosphorylation of the SH2-kinase linker.
    Yan Q; Barros T; Visperas PR; Deindl S; Kadlecek TA; Weiss A; Kuriyan J
    Mol Cell Biol; 2013 Jun; 33(11):2188-201. PubMed ID: 23530057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p56lck interactions accelerate autophosphorylation and enhance activity toward exogenous substrates.
    Wang S; Lehr R; Stevis P; Wang XM; Trevillyan J; Faltynek CR
    Arch Biochem Biophys; 1994 Nov; 315(1):60-7. PubMed ID: 7979406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the Lck SH2 domain by tyrosine phosphorylation.
    Couture C; Songyang Z; Jascur T; Williams S; Tailor P; Cantley LC; Mustelin T
    J Biol Chem; 1996 Oct; 271(40):24880-4. PubMed ID: 8798764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the Lck Src homology 2 and 3 domains in protein tyrosine phosphorylation.
    Lee-Fruman KK; Collins TL; Burakoff SJ
    J Biol Chem; 1996 Oct; 271(40):25003-10. PubMed ID: 8798782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel T cell antigen 4-1BB associates with the protein tyrosine kinase p56lck1.
    Kim YJ; Pollok KE; Zhou Z; Shaw A; Bohlen JB; Fraser M; Kwon BS
    J Immunol; 1993 Aug; 151(3):1255-62. PubMed ID: 8335927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation of a Src kinase at the autophosphorylation site in the absence of Src kinase activity.
    Chiang GG; Sefton BM
    J Biol Chem; 2000 Mar; 275(9):6055-8. PubMed ID: 10692391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors.
    Zhu X; Kim JL; Newcomb JR; Rose PE; Stover DR; Toledo LM; Zhao H; Morgenstern KA
    Structure; 1999 Jun; 7(6):651-61. PubMed ID: 10404594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.